참고문헌
- Y. Kishi, S. Ohta, N. Kasuya, T. Ashikaga and M. Isobe, Ibudilast, A Non-selective PDE Inhibitor with Multiple Actions on Blood Cells and Vascular Wall, Cardiovasc. Drug Rev., 19(3), 215-225 (2001) https://doi.org/10.1111/j.1527-3466.2001.tb00066.x
- L. C. D. Gibson, S. F. Hastings, I. McPhee, R. Rhee, A. Clatyon, C. E. Darroch, A. Mackenzie, P. A. Stevens and S. J. Mackenzie, The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family, Eur. J. Pharmacol., 538, 39-42 (2006) https://doi.org/10.1016/j.ejphar.2006.02.053
- J. Feng, T. Misu, K. Fujihara, S. Sakoda, Y. Nakatsuji, H. Fukaura, S. Kikuchi, K. Tashiro, A. Suzumura, N. Ishii, K. Sugamura, I. Nakashima and Y. Itoyama, Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Thl/Th2 balance and NKT cell subset in multiple sclerosis, Mult. Scler., 10, 494-498 (2004) https://doi.org/10.1191/1352458504ms1070oa
- T. Mizuno, T. Kurotani, Y. Komatsu, J. Kawanokuchi, H. Kato, N. Mitsuma and A. Suzumura, Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia, Neuropharmacology, 46, 404-411 (2004) https://doi.org/10.1016/j.neuropharm.2003.09.009
- M. Niwa, K. Kohno, L. Y. al Essa, M. Kobayashi, M. Nozaki and K. Tsurumi, Ibudilast, an anti-allergic and cerebral vasodilator, modulates superoxide production in human neutrophils, Life Sciences., 56, 107-115 (1995) https://doi.org/10.1016/0024-3205(94)00420-W
- W. M. Armstead, R. Mirro, C. W. Leffler and D. W. Busija, The role of prostanoids in the mediation of responses to KC-404, a novel cerebrovasodilator, J. Pharmacol. Exp. Ther., 244, 138-143 (1988)
- A. Kawasaki, K. Hoshino, R. Osaki, Y. Mizushima and S. Yano, Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma, J. Asthma., 29, 245-252 (1992) https://doi.org/10.3109/02770909209048938
- S. Yokogaki, Y. Suzuki and M. Ohashi, Introduction of a new anti-allergic ophthalmic solution: ibudilast ophtalmic solution (Ketas Eye drops), Jpn. J. Ocul. Pharmacol., 16, 24-28 (2002)
- K. Noguchi, K. Kobayashi, M. Nishikibe and F. Ikemeto, Preventive effect of ophthalmic ibudilast on experimental allergic conjunctivitis in the guinea pig, Journal of Eye., 11, 1747-1754 (1994)
- YANG Yi-Mei, CHEN Shu-Juan, Gu Shi-Fen, ZHANG Bin, DAI Zong-Shun and ZENG Fan-Dian, Pharmacokinetics and relative bioavailability of domestic ibudilast sustained release capsules in healthy volunteers, Chin J. Clin Pharmacol Ther., 5(4), 330-332 (2000)
- J. J. Torrado and L. L. Augsburger, Effect of different excipients on the tab1eting of coated particles, Int. J. Pharm., 106, 149-155 (1994) https://doi.org/10.1016/0378-5173(94)90313-1
- AR. Menjoge and MG. Kulkarni, Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release. Bio-macromolecules., 8(1), 240-51 (2007) https://doi.org/10.1021/bm060540+
- Jeong Young-II, Ohno Tomoya, Hu Zhaopeng, Yoshikawa Yukako, Nobuhito Shibata, Nagata Shunji and Takada Kanji, Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method, J. Control. Release., 71, 175-182 (2001) https://doi.org/10.1016/S0168-3659(01)00211-5
- N. Davies Peter, E. C. Harry, Worthington, Fridrun Podczeck and J. Michael Newton, The determination of the mechanical strength of tablets of different shapes, Eur. J. Pharm. Biopharm., 67, 268-276 (2007) https://doi.org/10.1016/j.ejpb.2007.01.014
- P. Rajniak, C. Mancinelli, R. T. Chern, F. Stepanek, L. Farber and B.T., Hill Experimental study of wet granulation in fluidized bed: Impact of the binder properties on the granule morphology, Int. J. Pharm., 334, 92-102 (2007) https://doi.org/10.1016/j.ijpharm.2006.10.040